Last reviewed · How we verify
KWA-0711
At a glance
| Generic name | KWA-0711 |
|---|---|
| Sponsor | Kissei Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC) (PHASE2)
- Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC) (PHASE2)
- Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects (PHASE1)
- A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation (PHASE2)
- A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation (PHASE2)
- A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |